top of page
Web Designing

Explain how the study will be conducted in accordance with ethical principles

The ethical conduct of a clinical investigation is of utmost importance to protect the safety, welfare, and rights of human subjects involved in the study. The following are some key ethical principles that should be followed in designing and conducting a clinical investigation:

  1. Informed Consent: Subjects should be fully informed about the study and its risks and benefits and provide voluntary informed consent to participate. The informed consent process should be documented.

  2. Privacy and Confidentiality: Subjects' privacy and confidentiality should be protected throughout the study. All study data should be de-identified and stored securely.

  3. Risk-Benefit Assessment: The risks and benefits of the study should be assessed, and the potential risks to subjects should be minimized while maximizing the potential benefits.

  4. Scientific Validity: The study should be scientifically valid and designed to answer the research question(s) being posed.

  5. Respect for Human Subjects: Subjects should be treated with respect and dignity throughout the study, and their rights should be protected.

To ensure that the clinical investigation is conducted in accordance with ethical principles, the study protocol should include the following information:

  1. Informed Consent Process: Describe how informed consent will be obtained from subjects, including how subjects will be informed about the study and their right to withdraw at any time.

  2. Privacy and Confidentiality: Describe how subjects' privacy and confidentiality will be protected throughout the study, including how study data will be collected, de-identified, and stored.

  3. Risk-Benefit Assessment: Describe the potential risks and benefits of the study, how risks will be minimized, and how benefits will be maximized.

  4. Scientific Validity: Describe how the study design will ensure the scientific validity and answer the research question(s) being posed.

  5. Respect for Human Subjects: Describe how subjects will be treated with respect and dignity throughout the study, including how their rights will be protected and any special considerations for vulnerable populations.

  6. Institutional Review Board (IRB): Describe how the study will be reviewed and approved by an independent IRB or ethics committee, and how any concerns or issues raised by the IRB will be addressed.

By including these details in the study protocol and adhering to ethical principles throughout the study, the clinical investigation can be conducted in a manner that ensures the safety, welfare, and rights of human subjects.

Designing of Protocol Synopsis of clinical study as per ISO 14155

ISO 14155 is an international standard that provides guidelines for designing, conducting, recording, and reporting clinical investigations involving medical devices. The protocol synopsis is an essential component of the clinical investigation plan, and it outlines the study's overall design, objectives, and methodology. Here is a brief outline of the sections that should be included in a protocol synopsis according to ISO 14155:

  1. Title and Background

    • The title should be concise and descriptive of the study's purpose.

    • The background should provide a brief overview of the medical device being investigated and the clinical need it addresses.

  2. Objectives

    • Clearly state the primary and secondary objectives of the study.

  3. Study Design

    • Describe the overall design of the study, including the study population, sample size, and study duration.

    • Describe the study procedures, including the intervention, if any, and any controls or comparisons used.

    • Describe the data collection methods, including any validated instruments or assessments used.

  4. Ethical Considerations

    • Explain how the study will be conducted in accordance with ethical principles, including obtaining informed consent, protecting subject confidentiality, and managing any potential conflicts of interest.

  5. Regulatory Requirements

    • Describe how the study will be conducted in accordance with applicable regulatory requirements, including obtaining necessary approvals and complying with reporting requirements.

  6. Data Analysis Plan

    • Describe how the data will be analyzed, including any statistical methods used.

  7. Study Timeline and Resources

    • ​Provide a detailed timeline for the study, including key milestones and anticipated completion date.

    • ​Describe the resources required to conduct the study, including personnel, facilities, and equipment.

  8. Conclusion

  • Summarize the overall purpose and design of the study.

It is important to note that this is just a brief overview, and additional sections or details may be required depending on the specific study and the requirements of the regulatory authorities involved. It is always recommended to consult with a regulatory expert to ensure compliance with all applicable regulations and guidelines.

Clinical study To get CE marking

 

CE marking is a certification that indicates that a product meets the safety, health, and environmental requirements set out by the European Union (EU). To obtain a CE marking for a medical device, the manufacturer needs to demonstrate that the device complies with the relevant EU regulations, including the Medical Devices Regulation (MDR) and the In-vitro Diagnostic Regulation (IVDR).

Clinical studies are often required as part of the CE marking process to demonstrate the safety and performance of the medical device. The type and extent of the clinical study required will depend on the classification of the device and the risk associated with its use.

For high-risk devices, such as implantable devices, a clinical investigation may be required. A clinical investigation involves the collection of clinical data on the safety and performance of the device in humans. The clinical investigation must be conducted in accordance with Good Clinical Practice (GCP) guidelines and must be approved by an ethics committee. The results of the clinical investigation must be included in the technical documentation submitted to the notified body for CE marking.

For lower-risk devices, such as some diagnostic devices, a clinical performance evaluation may be sufficient. A clinical performance evaluation involves reviewing existing clinical data on similar devices and collecting data on the performance of the device in a clinical setting. The clinical data must be collected in accordance with GCP guidelines and must be included in the technical documentation submitted to the notified body for CE marking.

In summary, the type and extent of clinical study required to obtain CE marking for a medical device will depend on the risk associated with its use. High-risk devices may require a clinical investigation, while lower-risk devices may require a clinical performance evaluation. Both types of studies must be conducted in accordance with GCP guidelines and must be included in the technical documentation submitted to the notified body for CE marking.

 

List of technical documents Required for the clinical study of medical devices 

The technical documentation required for a clinical study of a medical device may vary depending on the classification of the device and the nature of the study. However, here are some of the key technical documents that may be required:

  • Clinical investigation plan (CIP): This document outlines the objectives, design, methodology, and statistical analysis plan of the clinical study.

  • Informed consent form (ICF): This document informs the study participants about the nature and purpose of the study, its risks and benefits, and their rights and responsibilities.

  • Investigator's brochure (IB): This document provides essential information about the medical device, including its intended use, mechanism of action, safety profile, and any known or potential adverse effects.

  • Case report form (CRF): This document is used to collect data on the study participants, including their demographics, medical history, and study outcomes.

  • Protocol: This document provides detailed instructions on how the study will be conducted, including inclusion and exclusion criteria, treatment regimen, data collection procedures, and adverse event reporting requirements.

  • Ethics committee approval: This document is required for all clinical studies and confirms that the study protocol is in accordance with ethical principles and applicable regulations.

  • Investigational device exemption (IDE): This document is required for clinical studies of medical devices in the United States and confirms that the device is being used for investigational purposes and is not yet approved for commercial use.

  • Institutional review board (IRB) approval: This document is required for clinical studies conducted in the United States and confirms that the study protocol is in accordance with institutional policies and applicable regulations.

  • Adverse event reporting form: This document is used to report any adverse events or unexpected outcomes during the study.

  • Data management plan: This document outlines how the study data will be collected, managed, and analyzed, including quality control and data security procedures.

Overall, the technical documentation required for a clinical study of a medical device is extensive and requires careful planning, preparation, and execution to ensure the safety and efficacy of the device.


 

​

​

​

 

List of ISO guidelines required for the clinical study approval of the medical device

​

There are several ISO guidelines that are relevant to the approval of medical devices for a clinical study. Below is a list of some of the most important ones:

  • ISO 14155:2020 - Clinical investigation of medical devices for human subjects - Good clinical practice: This guideline sets out the principles and practices of good clinical practice for the design, conduct, recording, and reporting of clinical investigations carried out in humans to assess the safety or performance of medical devices for regulatory purposes.

  • ISO 10993-1:2018 - Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process: This guideline provides a framework for the biological evaluation of medical devices to ensure that they are safe for use in humans.

  • ISO 14971:2019 - Medical devices - Application of risk management to medical devices: This guideline provides a process for identifying and assessing risks associated with medical devices, and for managing those risks throughout the lifecycle of the device.

  • ISO 13485:2016 - Medical devices - Quality management systems - Requirements for regulatory purposes: This guideline specifies the requirements for a quality management system for medical device manufacturers to ensure that their products are safe and effective.

  • ISO 14160:2011 - Sterilization of health care products - Liquid chemical sterilizing agents for single-use medical devices utilizing animal tissues and their derivatives - Requirements for characterization, development, validation, and routine control of a sterilization process for medical devices: This guideline provides guidance on the validation and routine control of a sterilization process for medical devices that use animal tissues and their derivatives.

  • ISO 14644-1:2015 - Cleanrooms and associated controlled environments - Part 1: Classification of air cleanliness by particle concentration: This guideline specifies the classification of air cleanliness in cleanrooms and associated controlled environments to ensure that medical devices are manufactured in a clean and sterile environment.

These guidelines are not exhaustive, and there may be other ISO guidelines that are relevant to the approval of medical devices for clinical study, depending on the specific nature of the device and the clinical investigation being conducted.

bottom of page